The role of de novo ceramide synthesis in the mechanism of action of the tricyclic xanthate D609

Journal of Lipid Research

Volumn 45, Issue 1, 2004, Pages 164-173

  Perry, Ryan J ^a   Ridgway, Neale D ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Apoptosis; Brefeldin A; Endoplasmic reticulum export; Eukaryotic initiation factor 2 ; Fumonisin B1; Protein translation; Serine palmitoyltransferase

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; BREFELDIN A; CERAMIDE; CHELERYTHRINE; CYCLOSERINE; FUMONISIN B1; INITIATION FACTOR 2; THAPSIGARGIN; TRICYCLO[4.3.0.1]DECAN 9 YL XANTHOGENATE; XANTHIC ACID DERIVATIVE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL STRAIN 3T3; CHO CELL; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; GOLGI COMPLEX; HUMAN; HUMAN CELL; LIPOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RNA TRANSLATION;

ACYLTRANSFERASES; ANIMALS; APOPTOSIS; BREFELDIN A; BRIDGED COMPOUNDS; CASPASES; CERAMIDES; CRICETINAE; ENDOPLASMIC RETICULUM; EUKARYOTIC INITIATION FACTOR-2; FEMALE; FUMONISINS; MICE; PHOSPHORYLATION; POLY(ADP-RIBOSE) POLYMERASES; SERINE C-PALMITOYLTRANSFERASE; SPHINGOMYELINS; THIONES; TRANSFERASES (OTHER SUBSTITUTED PHOSPHATE GROUPS);

EID: 0842326180     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M300300-JLR200     Document Type: Article

References (51)

1. Hannun, Y. A. 1996. Functions of ceramide in coordinating cellular responses to stress. Science. 274: 1855-1859.
2. Hannun, Y. A., and C. Luberto. 2000. Ceramide in the eukaryotic stress response. Trends Cell Biol. 10: 73-80.
3. Chalfant, C. E., K. Kishikawa, M. C. Mumby, C. Kamibayashi, A. Bielawska, and Y. A. Hannun. 1999. Long chain ceramides activate protein phosphatase-1 and protein phosphatase-2A. Activation is stereospecific and regulated by phosphatidic acid. J. Biol. Chem. 274: 20313-20317.
4. Ruvolo, P. P., F. Gao, W. L. Blalock, X. Deng, and W. S. May. 2001. Ceramide regulates protein synthesis by a novel mechanism involving the cellular PKR activator RAX. J. Biol. Chem. 276: 11754-11758.
5. Verheij, M., R. Bose, X. H. Lin, B. Yao, W. D. Jarvis, S. Grant, M. J. Birrer, E. Szabo, L. I. Zon, J. M. Kyriakis, A. Haimovitz-Friedman, Z. Fuks, and R. N. Kolesnick. 1996. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature. 380: 75-79.
6. Lee, J. Y., Y. A. Hannun, and L. M. Obeid. 1996. Ceramide inactivates cellular protein kinase Calpha. J. Biol. Chem. 271: 13169-13174.
7. Westwick, J. K., A. E. Bielawska, G. Dbaibo, Y. A. Hannun, and D. A. Brenner. 1995. Ceramide activates the stress-activated protein kinases. J. Biol. Chem. 270: 22689-22692.
8. Dobrowsky, R. T., G. M. Jenkins, and Y. A. Hannun. 1995. Neurotrophins induce sphingomyelin hydrolysis. Modulation by coexpression of p75NTR with Trk receptors. J. Biol. Chem. 270: 22135-22142.
9. Kim, M. Y., C. Linardic, L. Obeid, and Y. Hannun. 1991. Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor alpha and gamma-interferon. Specific role in cell differentiation. J. Biol. Chem. 266: 484-489.
10. Kolesnick, R. N., A. Haimovitz-Friedman, and Z. Fuks. 1994. The sphingomyelin signal transduction pathway mediates apoptosis for tumor necrosis factor, Fas, and ionizing radiation. Biochem. Cell Biol. 72: 471-474.
11. Perry, D. K., J. Carton, A. K. Shah, F. Meredith, D.J. Uhlinger, and Y. A. Hannun. 2000. Serine palmitoyltransferase regulates de novo ceramide generation during etoposide-induced apoptosis. J. Biol. Chem. 275: 9078-9084.
12. Cabot, M. C., T. Y. Han, and A. E. Giuliano. 1998. The multidrug resistance modulator SDZ PSC 833 is a potent activator of cellular ceramide formation. FEBS Lett. 431: 185-188.
13. Bose, R., M. Verheij, A. Haimovitz-Friedman, K. Scotto, Z. Fuks, and R. Kolesnick. 1995. Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals. Cell. 82: 405-414.
14. Garzotto, M., M. White-Jones, Y. Jiang, D. Ehleiter, W. C. Liao, A. Haimoxitz-Friedman, Z. Fuks, and R. Kolesnick. 1998. 12-O-tetradecanoylphorbol-13-acetate-induced apoptosis in LNCaP cells is mediated through ceramide synthase. Cancer Res. 58: 2260-2264.
15. Suzuki, A., M. Iwasaki, M. Kato, and N. Wagai. 1997. Sequential operation of ceramide synthesis and ICE cascade in CPT-11-initiated apoptotic death signaling. Exp. Cell Res. 233: 41-47.
16. Boland, M. P., S. J. Foster, and L. A. O'Neill. 1997. Daunorubicin activates NFkappaB and induces kappaB-dependent gene expression in HL-60 promyelocytic and Jurkat T lymphoma cells. J. Biol. Chem. 272: 12952-12960.
17. Hirschberg, K., J. Rodger, and A. H. Futerman. 1993. The long-chain sphingoid base of sphingolipids is acylated at the cytosolic surface of the endoplasmic reticulum in rat liver. Biochem. J. 290: 751-757.
18. Fukasawa, M., M. Nishijima, and K. Hanada. 1999. Genetic evidence for ATP-dependent endoplasmic reticulum-to-Golgi apparatus trafficking of ceramide for sphingomyelin synthesis in Chinese hamster ovary cells. J. Cell Biol. 144: 673-685.
19. Xu, J., C. H. Yeh, S. Chen, L. He, S. L. Sensi, L. M. Canzoniero, D. W. Choi, and C. Y. Hsu. 1998. Involvement of de novo ceramide biosynthesis in tumor necrosis factor-alpha/cycloheximide-induced cerebral endothelial cell death. J. Biol. Chem. 273: 16521-16526.
20. Birbes, H., S. El Bawab, Y. A. Hannun, and L. M. Obeid. 2001. Selective hydrolysis of a mitochondrial pool of sphingomyelin induces apoptosis. FASEB J. 15: 2669-2679.
21. Luberto, C., D. S. Yoo, H. S. Suidan, G. M. Bartoli, and Y. A. Hannun. 2000. Differential effects of sphingomyelin hydrolysis and resynthesis on the activation of NF-kappa B in normal and SV40-transformed human fibroblasts. J. Biol. Chem. 275: 14760-14766.
22. Amtmann, E. 1996. The antiviral, antitumural xanthate D609 is a competitive inhibitor of phosphatidylcholine-specific phospholipase C. Drugs Exp. Clin. Res. 22: 287-294.
23. Muller-Decker, K., C. Doppler, E. Amtmann, and G. Sauer. 1988. Interruption of growth signal transduction by an antiviral and antitumoral xanthate compound. Exp. Cell Res. 177: 295-302.
24. Antony, P., A. A. Farooqui, L. A. Horrocks, and L. Freysz. 2001. Effect of D609 on phosphatidylcholine metabolism in the nuclei of LA-N-1 neuroblastoma cells: a key role for diacylglycerol. FEBS Lett. 509: 115-118.
25. Barbin, G., M. P. Roisin, and B. Zalc. 2001. Tumor necrosis factor alpha activates the phosphorylation of ERK, SAPK/JNK, and P38 kinase in primary cultures of neurons. Neurochem. Res. 26: 107-112.
26. Zhou, D., C. M. Lauderback, T. Yu, S. A. Brown, D. A. Butterfield, and J. S. Thompson. 2001. D609 inhibits ionizing radiation-induced oxidative damage by acting as a potent antioxidant. J. Pharmacol. Exp. Ther. 298:103-109.
27. Giron-Calle, J., K. Srivatsa, and H. J. Forman. 2002. Priming of alveolar macrophage respiratory burst by H(2)O(2) is prevented by phosphatidylcholine-specific phospholipase C inhibitor tricyclodecan-9-yl-xanthate (D609). J. Pharmacol. Exp. Ther. 301: 87-94.
28. Gonzalez-Roura, A., J. Casas, and A. Llebaria. 2002. Synthesis and phospholipase C inhibitory activity of D609 diastereomers. Lipids. 37: 401-406.
29. Stonehouse, M. J., A. Cota-Gomez, S. K. Parker, W. E. Martin, J. A. Hankin, R. C. Murphy, W. Chen, K. B. Lim, M. Hackett, A. I. Vasil, and M. L. Vasil. 2002. A novel class of microbial phosphocholine-specific phospholipases C. Mol. Microbiol. 46: 661-676.
30. Singh, A. T., J. M. Radeff, J. G. Kunnel, and P. H. Stern. 2000. Phosphatidylcholine-specific phospholipase C inhibitor, tricyclodecan-9-yl xanthogenate (D609), increases phospholipase D-mediated phosphatidylcholine hydrolysis in UMR-106 osteoblastic osteosarcoma cells. Biochim. Biophys. Acta. 1487: 201-208.
31. Lefrancois, S., T. May, C. Knight, D. Bourbeau, and C. R. Morales. 2002. The lysosomal transport of prosaposin requires the conditional interaction of its highly conserved d domain with sphingomyelin. J. Biol. Chem. 277: 17188-17199.
32. Ridgway, N. D. 1995. 25-Hydroxycholesterol stimulates sphingomyelin synthesis in Chinese hamster ovary cells. J. Lipid Res. 36: 1345-1358.
33. Ridgway, N. D., and D. L. Merriam. 1995. Metabolism of short-chain ceramide and dihydroceramide analogues in Chinese hamster ovary (CHO) cells. Biochim. Biophys. Acta. 1256: 57-70.
34. Preiss, J., C. R. Loomis, W. R. Bishop, R. Stein, J. E. Niedel, and R. M. Bell. 1986. Quantitative measurement of sn-1,2-diacylglycerols present in platelets, hepatocytes, and ras- and sis-transformed normal rat kidney cells. J. Biol. Chem. 261: 8597-8600.
35. Lowry, O. H., N.J. Rosebrough, A. L. Farr, and R.J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275.
36. Merrill, A. H., Jr. 1983. Characterization of serine palmitoyltransferase activity in Chinese hamster ovary cells. Biochim. Biophys. Acta. 754: 284-291.
37. Futerman, A. H., and R. E. Pagano. 1992. Use of N-[1-14C]hexanoyl)-D-erythro-sphingolipids to assay sphingolipid metabolism. Methods Enzymol. 209: 437-446.
38. Yasuda, S., H. Kitagawa, M. Ueno, H. Ishitani, M. Fukasawa, M. Nishijima, S. Kobayashi, and K. Hanada. 2001. A novel inhibitor of ceramide trafficking from the endoplasmic reticulum to the site of sphingomyelin synthesis. J. Biol. Chem. 276: 43994-44002.
39. Mohammadi, A., R. J. Perry, M. K. Storey, H. W. Cook, D. M. Byers, and N. D. Ridgway. 2001. Golgi localization and phosphorylation of oxysterol binding protein in Niemann-Pick C and U18666A-treated cells. J. Lipid Res. 42: 1062-1071.
40. Proud, C. G. 1992. Protein phosphorylation in translational control. Curr. Top. Cell. Regul. 32: 243-369.
41. Dever, T. E. 1999. Translation initiation: adept at adapting. Trends Biochem. Sci. 24: 398-403.
42. Ito, T., M. Yang, and W. S. May. 1999. RAX, a cellular activator for double-stranded RNA-dependent protein kinase during stress signaling. J. Biol. Chem. 274: 15427-15432.
43. Ridgway, N. D., T. A. Lagace, H. W. Cook, and D. M. Byers. 1998. Differential effects of sphingomyelin hydrolysis and cholesterol transport on oxysterol-binding protein phosphorylation and Golgi localization. J. Biol. Chem. 273: 31621-31628.
44. Ridgway, N. D., K. Badiani, D. M. Byers, and H. W. Cook. 1998. Inhibition of phosphorylation of the oxysterol binding protein by brefeldin A. Biochim. Biophys. Acta. 1390: 37-51.
45. Bruning, A., A. Karrenbauer, E. Schnabel, and F. T. Wieland. 1992. Brefeldin A-induced increase of sphingomyelin synthesis. Assay for the action of the antibiotic in mammalian cells. J. Biol. Chem. 267: 5052-5055.
46. Ridgway, N. D., and T. A. Lagace. 1995. Brefeldin A renders Chinese hamster ovary cells insensitive to transcriptional suppression by 25-hydroxycholesterol. J. Biol. Chem. 270: 8023-8031.
47. Lagace, T. A., D. M. Byers, H. W. Cook, and N. D. Ridgway. 1999. Chinese hamster ovary cells overexpressing the oxysterol binding protein (OSBP) display enhanced synthesis of sphingomyelin in response to 25-hydroxycholesterol. J. Lipid Res. 40: 109-116.
48. Pagano, R. E., R. Watanabe, C. Wheatley, and M. Dominguez. 2000. Applications of BODIPY-sphingolipid analogs to study lipid traffic and metabolism in cells. Methods Enzymol. 312: 523-534.
49. Luberto, C., and Y. A. Hannun. 1998. Sphingomyelin synthase, a potential regulator of intracellular levels of ceramide and diacylglycerol during SV40 transformation. Does sphingomyelin synthase account for the putative phosphatidylcholine-specific phospholipase C? J. Biol. Chem. 273: 14550-14559.
50. Erdreich-Epstein, A., L. B. Tran, N. N. Bowman, H. Wang, M. C. Cabot, D. L. Durden, J. Vlckova, C. P. Reynolds, M. F. Stins, S. Groshen, and M. Millard. 2002. Ceramide signaling in fenretinide-induced endothelial cell apoptosis. J. Biol. Chem. 277: 49531-49537.
51. Patel, C. V., I. Handy, T. Goldsmith, and R. C. Patel. 2000. PACT, a stress-modulated cellular activator of interferon-induced double-stranded RNA-activated protein kinase, PKR. J. Biol. Chem. 275: 37993-37998.